First Monday is back from the summer break.🏝️☀️

On Sept 5th, we will have Tamás Petrovics (CEO & Co-Founder of XUND) with us to chat about his lessons learned while starting and growing his company.

XUND provides an API certified as a Class IIa medical device to help healthcare ecosystem players building their own symptom assessment and patient navigating systems. They have recently raised a mid-seven-figure seed round. The growing team split between Vienna and Budapest is committed to providing the best tools for digitizing the patient journey.

We will chat about finding Product Market Fit, second mover advantage, accelerating compliance, fundraising, and more.

About XUND:

XUND enables healthcare companies to digitize the patient journey and translate data into real-world evidence. Founded in Vienna in 2018, the company’s flagship product is an AI-powered health assistant that provides symptom and risk assessment capabilities to help navigate patients to the best point of care. The underlying database is powered by proprietary NLP models analyzing millions of medical publications. The technology is certified as a Class IIa medical device under the European Medical Device Regulation (MDR) and utilized by market-leading insurance, pharma, and big tech companies.

About the speaker:

Tamás Petrovics is Co-Founder & CEO of the healthtech start-up XUND. Born in Hungary, he has now been living in Vienna for more than 20 years. He gained several years of international consulting experience at Brunswick Group and McKinsey & Company after graduating from WU Vienna.

Tamás left consulting and founded XUND together with his longtime friends Lukas Seper and Dr. Zoltán Tarabó back in 2018. Tamás’ vision is to improve the access to healthcare by putting people first. With XUND, he enables healthcare companies to build their own digital patient journey and transform unstructured data collected from the patient into actionable insights. The company’s flagship product is an AI-powered Medical API that provides symptom and risk assessment capabilities to help navigate patients to the best point of care. The underlying database is powered by the automated analysis of more than 2 million medical publications through proprietary NLP solutions. The technology is certified as a Class IIa medical device under MDR and is used by market-leading insurance, pharmaceutical & big tech companies in a licensing model. Besides the Vienna headquarters, the start-up also runs an office in Budapest and currently employs more than 35 people.

Powered by